Our Solution
Our Solution
EPISEEK™
Multi-Cancer Early Detection Test
EPISEEK™ is a unique DNA methylation cancer biomarker set capable of detecting most common cancers through a simple blood draw. Patent issued 2023.
EPISEEK™ is a unique DNA methylation cancer biomarker set capable of detecting most common cancers through a simple blood draw. Patent issued 2023.